Action Required: Password Reset on Next Login

As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.

To reset your password, please visit the Reset Password page.

We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
DATA GRAPHICS | Finance

Valuations spiral into billions as trio of IPOs post big aftermarket gains: Data Byte

March 26, 2021 8:33 PM UTC

Design Therapeutics became the latest preclinical company to score a billion-dollar valuation as it went public ahead of Friday’s session, and its shares more than doubled in value during the day.

The company was one of three biopharmas to go public ahead of trading Friday, alongside Edgewise Therapeutics Inc. (NASDAQ:EWTX) and Ikena Oncology Inc. (NASDAQ:IKNA), both of which also rose sharply in value amid high demand...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article